Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6501
Invesco Dividend Achievers ETF
PFM
$810M
| $1.09M | ﹤0.01% |
+29,695
| New | +$1.09M |
|
|
SAGE
6502
CALL
DELISTED
Sage Therapeutics
SAGE
| $1.09M | ﹤0.01% |
25,900
-49,100
| -65% | -$2.11M |
|
|
OSG
6503
PUT
Octave Specialty Group
OSG
$221M
| $1.09M | ﹤0.01% |
70,200
+53,700
| +325% | +$869K |
|
6504
CALL
Alamo Group
ALG
$2.01B
| $1.09M | ﹤0.01% |
5,900
+5,500
| +1,375% | +$905K |
|
6505
Eldorado Gold
EGO
$10.4B
| $1.09M | ﹤0.01% |
104,853
-163,553
| -61% | -$1.52M |
|
6506
Eastman Chemical
EMN
$8.47B
| $1.09M | ﹤0.01% |
12,879
+4,936
| +62% | +$424K |
|
6507
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
| $1.09M | ﹤0.01% |
17,419
+15,219
| +692% | +$935K |
|
6508
Tradr 2X Long Innovation ETF
TARK
$16.3M
| $1.09M | ﹤0.01% |
+33,754
| New | +$1.02M |
|
6509
PUT
Essent Group
ESNT
$6.25B
| $1.09M | ﹤0.01% |
27,100
+25,300
| +1,406% | +$1.04M |
|
6510
Vident US Bond Strategy ETF
VBND
$525M
| $1.09M | ﹤0.01% |
24,782
-8,958
| -27% | -$390K |
|
|
CPRX
6511
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.08M | ﹤0.01% |
65,400
+40,000
| +157% | +$660K |
|
6512
CALL
Direxion Daily Energy Bear 2X ETF
ERY
$35.4M
| $1.08M | ﹤0.01% |
35,300
-35,300
| -50% | -$1.06M |
|
6513
PUT
iShares Russell Mid-Cap ETF
IWR
$58.4B
| $1.08M | ﹤0.01% |
15,500
+900
| +6% | +$63.5K |
|
6514
PUT
iShares Core US REIT ETF
USRT
$4.64B
| $1.08M | ﹤0.01% |
+21,500
| New | +$1.11M |
|
6515
PUT
Ascendis Pharma A/S
ASND
$16.3B
| $1.08M | ﹤0.01% |
10,100
-21,800
| -68% | -$2.49M |
|
6516
CALL
Insteel Industries
IIIN
$631M
| $1.08M | ﹤0.01% |
38,900
+18,200
| +88% | +$529K |
|
6517
CALL
Endava
DAVA
$164M
| $1.08M | ﹤0.01% |
16,100
+5,700
| +55% | +$448K |
|
6518
BNY Mellon Concentrated International ETF
BKCI
$134M
| $1.08M | ﹤0.01% |
+23,240
| New | +$1.04M |
|
|
ZEUS
6519
CALL
DELISTED
Olympic Steel
ZEUS
| $1.08M | ﹤0.01% |
20,700
+6,600
| +47% | +$305K |
|
6520
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.42B
| $1.08M | ﹤0.01% |
13,407
+6,268
| +88% | +$523K |
|
6521
PUT
TriNet
TNET
$3.16B
| $1.08M | ﹤0.01% |
13,400
-13,800
| -51% | -$1.08M |
|
6522
Adeia
ADEA
$3.29B
| $1.08M | ﹤0.01% |
121,909
+43,970
| +56% | +$440K |
|
6523
Banco de Chile
BCH
$20.6B
| $1.08M | ﹤0.01% |
55,292
-169,296
| -75% | -$3.51M |
|
6524
Inogen
INGN
$153M
| $1.08M | ﹤0.01% |
+86,432
| New | +$1.65M |
|
6525
Quanex
NX
$962M
| $1.08M | ﹤0.01% |
50,095
+16,275
| +48% | +$391K |
|
Similar funds
Citadel Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.
- Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Citadel Advisors opened 1,466 new positions and closed 1,652 in Q1 2023.
- Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.